Type 1 Diabetes Development Requires Both CD4+ and CD8+ T cells and Can Be Reversed by Non-Depleting Antibodies Targeting Both T Cell Populations . (2023). The Review of Diabetic Studies , 6(2). https://diabeticstudies.org/index.php/RDS/article/view/259